FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4902711000001102: Tranxene 15mg capsules (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18289901000001112 Tranxene 15mg capsules (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18290001000001115 Tranxene 15mg capsules (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Is a Product containing precisely dipotassium clorazepate 15 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has active ingredient Dipotassium clorazepate false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Is a Tranxene true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has specific active ingredient Dipotassium clorazepate true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 100 capsule Is pack of False Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Is pack of False Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 100 capsule Has AMP True Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has AMP True Tranxene 15mg capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start